DaVita Raises Annual Profit Forecast After Q1 Earnings Beat Wall Street Estimates

Key Facts

DaVita (DVA) shares surged 20% to a new all-time high after reporting a non-GAAP EPS of $2.87, significantly beating consensus estimates. The company's operational strength was highlighted by a first-quarter revenue of $3.5 billion and an expanded adjusted operating margin of 19.1%. Following these results, Barclays analyst Andrew Mok raised the price target for DVA to $194.00 from $158.00. Furthermore, DaVita raised its full-year 2026 adjusted EPS forecast to a specific range of $14.10 to $15.20, reinforcing its mid-teens growth trajectory. This outlook is underpinned by a robust free cash flow yield exceeding 10%, signaling strong capital efficiency. Analysts believe these updated metrics and specific long-term targets underscore the company's strategic resilience and dominant position in the healthcare sector.

Version History